| Original language | English (US) |
|---|---|
| Pages (from-to) | 1761-1763 |
| Number of pages | 3 |
| Journal | Bone Marrow Transplantation |
| Volume | 56 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2021 |
ASJC Scopus subject areas
- Hematology
- Transplantation
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population. / Shapiro, Lauren C.; Mustafa, Jennat; Lombardo, Amanda; Khatun, Fariha; Joseph, Felisha; Gillick, Kailyn; Naik, Anjali; Elkind, Richard; Abreu, Michelly; Fehn, Karen; de Castro, Alyssa; Pradhan, Kith; Binakaj, Donika; Nelson, Randin; Paroder, Monika; Uehlinger, Joan; Gritsman, Kira; Alejandro Sica, R.; Kornblum, Noah; Shastri, Aditi; Mantzaris, Ioannis; Bachier-Rodriguez, Lizamarie; Verma, Amit; Braunschweig, Ira; Goldfinger, Mendel.
In: Bone Marrow Transplantation, Vol. 56, No. 7, 07.2021, p. 1761-1763.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population
AU - Shapiro, Lauren C.
AU - Mustafa, Jennat
AU - Lombardo, Amanda
AU - Khatun, Fariha
AU - Joseph, Felisha
AU - Gillick, Kailyn
AU - Naik, Anjali
AU - Elkind, Richard
AU - Abreu, Michelly
AU - Fehn, Karen
AU - de Castro, Alyssa
AU - Pradhan, Kith
AU - Binakaj, Donika
AU - Nelson, Randin
AU - Paroder, Monika
AU - Uehlinger, Joan
AU - Gritsman, Kira
AU - Alejandro Sica, R.
AU - Kornblum, Noah
AU - Shastri, Aditi
AU - Mantzaris, Ioannis
AU - Bachier-Rodriguez, Lizamarie
AU - Verma, Amit
AU - Braunschweig, Ira
AU - Goldfinger, Mendel
N1 - Funding Information: Conflict of interest Dr RAS serves as a consultant with Morphosys and Miragen and is on the faculty at Physicians’ Education Research. Dr AS has received research funding from Kymera Therapeutics and serves as a consultant with Guidepoint, GLG. Dr AV has received research funding from BMS, Jannsen, and has equity stake in Stelexis Inc. The remaining authors declare no competing interests.
PY - 2021/7
Y1 - 2021/7
UR - http://www.scopus.com/inward/record.url?scp=85104144772&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104144772&partnerID=8YFLogxK
U2 - 10.1038/s41409-021-01280-3
DO - 10.1038/s41409-021-01280-3
M3 - Letter
C2 - 33846558
AN - SCOPUS:85104144772
VL - 56
SP - 1761
EP - 1763
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
SN - 0268-3369
IS - 7
ER -